Cardiac effects of endothelin receptor antagonism in endotoxemic pigs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 2, 2007, Pages

  Konrad, D ^a,c   Haney, M ^b   Johansson, G ^b   Wanecek, M ^a   Weitzberg, E ^a   Oldner, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diastolic; End systolic elastance; Endotoxin; Inotropy; Sepsis

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; TAU PROTEIN; TEZOSENTAN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; DRUG MECHANISM; ENDOTOXEMIA; FEMALE; HEART; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART PRELOAD; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART WORK; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SWINE;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTOXEMIA; ENDOTOXINS; FEMALE; HEART RATE; MYOCARDIAL CONTRACTION; OXYGEN CONSUMPTION; PYRIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SUS SCROFA; TETRAZOLES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 34547901052     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01023.2006     Document Type: Article

References (65)

1. Abel FL, Krosl P, Redl H. Beat-to-beat evaluation of cardiac function in low-dose endotoxemia using a conscious sheep model. Shock 16: 368-372, 2001.
2. Aghajani E, Korvald C, Nordhaug D, Revhaug A, Myrmel T. Increased oxygen cost of contractility in the endotoxemic porcine left ventricle. Scand Cardiovasc J 38: 187-192, 2004.
3. Aghajani E, Korvald C, Nordhaug D, Sager G, Revhaug A, Myrmel TE. Coli sepsis induces profound mechanoenergetic inefficiency in the porcine left ventricle. Shock 21: 103-109, 2004.
4. Awane-Igata Y, Ikeda S, Watanabe T. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Br J Pharmacol 120: 516-522, 1997.
5. Beyer ME, Slesak G, Brehm BR, Hoffmeister HM. Hemodynamic and inotropic effects of the endothelin A antagonist BQ-610 in vivo. J Cardiovasc Pharmacol 31, Suppl 1: S258-S261, 1998.
6. Brahmbhatt S, Gupta A, Sharma AC. Bigendothelin-1 (1-21) fragment during early sepsis modulates tau, p38-MAPK phosphorylation and nitric oxide synthase activation. Mol Cell Biochem 271: 225-237, 2005.
7. Brauner JS, Rohde LE, Clausell N. Circulating endothelin-1 and tumor necrosis factor-alpha: early predictors of mortality in patients with septic shock. Intensive Care Med 26: 305-313, 2000.
8. Broome M, Haney M, Osterlund B, Haggmark S, Johansson G, Biber B. The cardiac effects of intracoronary angiotensin II infusion. Anesth Analg 94: 787-793, 2002.
9. Brutsaert DL, Sys SU. Relaxation and diastole of the heart. Physiol Rev 69: 1228-1315, 1989.
10. Chin A, Radhakrishnan J, Fornell L, John E. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock. J Pediatr Surg 37: 482-487, 2002.
11. Clozel M, Ramuz H, Clozel JP, Breu V, Hess P, Loffler BM, Coassolo P, Roux S. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Exp Ther 290: 840-846, 1999.
12. Constable PD. Acute endotoxemia increases left ventricular contractility and diastolic stiffness in calves. Shock 12: 391-401, 1999.
13. Court O, Kumar A, Parrillo JE. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 6: 500-508, 2002.
14. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. The coronary circulation in human septic shock. Circulation 73: 637-644, 1986.
15. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797-9800, 1988.
16. Dupuis J, Goresky CA, Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol 81: 1510-1515, 1996.
17. Filep JG, Foldes-Filep E, Rousseau A, Sirois P, Fournier A. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 110: 1213-1221, 1993.
18. Glower DD, Spratt JA, Snow ND, Kabas JS, Davis JW, Olsen CO, Tyson GS, Sabiston DC Jr, Rankin JS. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71: 994-1009, 1985.
19. Goldberg AT, Bond BR, Mukherjee R, New RB, Zellner JL, Crawford FA Jr, Spinale FG. Endothelin receptor pathway in human left ventricular myocytes: relation to contractility. Ann Thorac Surg 69: 711-715; discussion 716, 2000.
20. Gupta A, Brahmbhatt S, Kapoor R, Loken L, Sharma AC. Chronic peritoneal sepsis: myocardial dysfunction, endothelin and signaling mechanisms. Front Biosci 10: 3183-3205, 2005.
21. Haney MF, Johansson G, Haggmark S, Biber B. Method of preload reduction during LVPVR analysis of systolic function: airway pressure elevation and vena cava occlusion. Anesthesiology 97: 436-446, 2002.
22. Hemsen A. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Physiol Scand Suppl 602: 1-61, 1991.
23. Ishihara S, Ward JA, Tasaki O, Pruitt BA Jr, Javors MA, Cassidy RA, Mozingo DW. Biphasic changes in left ventricular function during hyperdynamic endotoxemia. Am J Physiol Regul Integr Comp Physiol 276: R1516-R1524, 1999.
24. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation 76: 1422-1436, 1987.
25. Kelso EJ, McDermott BJ, Silke B, Spiers JP. Endothelin(A) receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium. J Pharmacol Exp Ther 294: 1047-1052, 2000.
26. Khadour FH, Panas D, Ferdinandy P, Schulze C, Csont T, Lalu MM, Wildhirt SM, Schulz R. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol 283: H1108-H1115, 2002.
27. Kiely DG, Cargill RI, Struthers AD, Lipworth BJ. Cardiopulmonary effects of endothelin-1 in man. Cardiovasc Res 33: 378-386, 1997.
28. Kline JA, Gordon BE, Williams C, Blumenthal S, Watts JA, Diaz-Buxo J. Large-pore hemodialysis in acute endotoxin shock. Crit Care Med 27: 588-596, 1999.
29. Konrad D, Oldner A, Rossi P, Wanecek M, Rudehill A, Weitzberg E. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock. Crit Care Med 32: 1192-1199, 2004.
30. Konrad D, Oldner A, Wanecek M, Rudehill A, Weitzberg E, Biber B, Johansson G, Haggmark S, Haney M. Positive inotropic and negative lusitropic effects of endothelin receptor agonism in vivo. Am J Physiol Heart Circ Physiol 289: H1702-H1709, 2005.
31. Kumar A, Krieger A, Symeoneides S, Parrillo JE. Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 15: 485-511, 2001.
32. Lee K, van der Zee H, Dziuban SW Jr, Luhmann K, Goldfarb RD. Left ventricular function during chronic endotoxemia in swine. Am J Physiol Heart Circ Physiol 254: H324-H330, 1988.
33. MacCarthy PA, Grocott-Mason R, Prendergast BD, Shah AM. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation 101: 142-147, 2000.
34. Mebazaa A, De Keulenaer GW, Paqueron X, Andries LJ, Ratajczak P, Lanone S, Frelin C, Longrois D, Payen D, Brutsaert DL, Sys SU. Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide. Circulation 104: 3137-3144, 2001.
35. Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res 59: 745-754, 2003.
36. Merkus D, Houweling B, van den Meiracker AH, Boomsma F, Duncker DJ. Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. Am J Physiol Heart Circ Physiol 288: H871-H880, 2005.
37. Mirsky I. Assessment of diastolic function: suggested methods and future considerations. Circulation 69: 836-841, 1984.
38. Modesti PA, Vanni S, Paniccia R, Perna A, Maccherini M, Lisi G, Sani G, Neri Serneri GG. Endothelin receptors in adult human and swine isolated ventricular cardiomyocytes. Biochem Pharmacol 58: 369-374, 1999.
39. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538, 1993.
40. Munt B, Jue J, Gin K, Fenwick J, Tweeddale M. Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 26: 1829-1833, 1998.
41. Nakayama M, Chen CH, Nevo E, Fetics B, Wong E, Kass DA. Optimal preload adjustment of maximal ventricular power index varies with cardiac chamber size. Am Heart J 136: 281-288, 1998.
42. Ognibene FP, Parker MM, Natanson C, Shelhamer JH, Parrillo JE. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 93: 903-910, 1988.
43. Oldner A, Wanecek M, Weitzberg E, Sundin P, Sollevi A, Rubio C, Hellstrom PM, Alving K, Rudehill A. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia. Br J Pharmacol 127: 1793-1804, 1999.
44. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97: 126-131, 1990.
45. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483-490, 1984.
46. Pinsky MR, Rico P. Cardiac contractility is not depressed in early canine endotoxic shock. Am J Respir Crit Care Med 161: 1087-1093, 2000.
47. Plumpton C, Ashby MJ, Kuc RE, O'Reilly G, Davenport AP. Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) 90: 37-46, 1996.
48. Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 23: 553-560, 1997.
49. Sakurai K, Norota I, Tanaka H, Kubota I, Tomoike H, Endo M. Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sci 70: 1173-1184, 2002.
50. Smith LW, McDonough KH. Inotropic sensitivity to beta-adrenergic stimulation in early sepsis. Am J Physiol Heart Circ Physiol 255: H699-H703, 1988.
51. Steendijk P, Staal E, Jukema JW, Baan J. Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281: H755-H763, 2001.
52. Steendijk P, Van der Velde ET, Baan J. Left ventricular stroke volume by single and dual excitation of conductance catheter in dogs. Am J Physiol Heart Circ Physiol 264: H2198-H2207, 1993.
53. Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, Spinale FG. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol Heart Circ Physiol 271: H2629-H2637, 1996.
54. Torre-Amione G, Young JB, Durand J, Bozkurt B, Mann DL, Kobrin I, Pratt CM. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation 103: 973-980, 2001.
55. Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J. Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28: 1854-1860, 2000.
56. Wanecek M, Oldner A, Rudehill A, Sollevi A, Alving K, Weitzberg E. Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan. Shock 7: 364-370, 1997.
57. Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock. Eur J Pharmacol 386: 235-245, 1999.
58. Wanecek M, Weitzberg E, Alving K, Rudehill A, Oldner A. Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock. Acta Anaesthesiol Scand 45: 1262-1270, 2001.
59. Wanecek M, Weitzberg E, Rudehill A, Oldner A. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 407: 1-15, 2000.
60. Watanabe T, Kusumoto K, Kitayoshi T, Shimamoto N. Positive inotropic and vasoconstrictive effects of endothelin-1 in in vivo and in vitro experiments: characteristics and the role of L-type calcium channels. J Cardiovasc Pharmacol 13 Suppl 5: S108-S111; discussion S123, 1989.
61. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 33: 222-227, 1991.
62. Werner HA, Herbertson MJ, Walley KR. Amrinone increases ventricular contractility and diastolic compliance in endotoxemia. Am J Respir Crit Care Med 152: 496-503, 1995.
63. Winegrad S. Endothelial cell regulation of contractility of the heart. Annu Rev Physiol 59: 505-525, 1997.
64. Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 85: 6964-6967, 1988.
65. 2+ transient and contractility in rabbit ventricular myocytes: pharmacological analysis with KB-R7943. Br J Pharmacol 126: 1785-1795, 1999.